Search

Byline: Varsha Agarwal The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent in response to representations from drug makers. India's [...]

ALEXANDRIA, VA -- The following information was released by the National Community Pharmacists Association (NCPA): How do you approach rescue therapy for your patients with asthma? Explore data on new [...]

LOS ANGELES, CA -- The following information was released by UCLA Health System: Diverse team of healthcare providers provides patients with multi-disciplinary and personalized approach to asthma care, management and [...]

ALEXANDRIA, VA -- The following information was released by the National Community Pharmacists Association (NCPA): How do you approach rescue therapy for your patients with asthma? Explore data on new [...]

PASADENA: Arrowhead Pharmaceuticals, Inc., announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the [...]

- Funding secured from CF Foundation and current investors for SPL84 Phase 2 study - - Two additional early-stage candidates expected to commence Phase 1-2a studies over the next 12 [...]

Byline: Weronika Strzyzynska and Kaamil Ahmed Four months of conflict in Gaza is jeopardising the health of thousands of people with chronic illnesses such as kidney disease, diabetes and asthma, [...]

WASHINGTON, Feb. 25, 2024 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as 'Longbio Pharma'), a leading biotech company dedicated to developing innovative protein treatments for allergy, respiratory, dermatology, [...]

NEW YORK: Intrommune Therapeutics, Inc., announces data from The First Study To Evaluate Oral Mucosal Immunotherapy For The Treatment Of Food Allergy has been selected as a Late Breaking Poster [...]

Byline: Opinion by Rob Davidson (CNN) -- (CNN) — Editor's note: Rob Davidson is an emergency physician in Michigan and executive director of the Committee to Protect Health Care, an [...]

Byline: Meg Tirrell, CNN (CNN) -- (CNN) — Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors [...]

SAN DIEGO: Connect Biopharma Holdings Limited (Nasdaq: CNTB) ('Connect Biopharma' or the 'Company'), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through [...]

BOSTON: OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, announced the launch of two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. Both [...]

Byline: By, Amy Walters & Charlotte Partis-Nelson A woman and her cat have earned a following online after raising awareness for feline asthma -- with treatment costing her over £25,000. [...]

WAYNE, Pa. and ROCKVILLE, Md: Avalo Therapeutics has issued the following news release: Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced topline results from the Phase 2 randomized, double-blind, placebo-controlled trial [...]

FAIRFAX, VA -- The following information was released by the Allergy & Asthma Network: How to ensure asthma and allergy patients get the medications they need when they need it? [...]

Supported by premier life science industry investors Canaan, OrbiMed, and Hatteras Venture Partners Proceeds to advance AER-01 into the clinic for treatment of chronic obstructive pulmonary disease (COPD); unique targeted [...]

SOUTH SAN FRANCISCO, Calif: RAPT Therapeutics, Inc. has issued the following news release: RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's 'Asthma Pipeline Insight - 2023' report provides comprehensive global coverage of available, marketed, and pipeline asthma therapies [...]

Asthma is a chronic disease that affects a substantial number of patients worldwide, including children, a number of pharmaceutical companies are involved in developing drugs for asthma. This involvement includes [...]

LEXINGTON, Mass., Feb. 6, 2023 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3775499-1&h=1424136920&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&a=Pulmatrix%2C+Inc.(NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease using its patented iSPERSE(TM) technology, today announced the first [...]

DUBLIN, Jan. 6, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5671197/connected-drug-delivery-devices-market-by-type?utm_source=CI&utm_medium=PressRelease&utm_code=g2dm79&utm_campaign=1802541+-+The+Worldwide+Connected+Drug+Delivery+Devices+Industry+is+Expected+to+Reach+%242+Billion+by+2030&utm_exec=jamu273prd report has been added toResearchAndMarkets.com's offering. The global connected drug delivery devices market is envisioned to garner $2,095.2 million by 2030, growing [...]

BEIJING, Dec. 14, 2022 /PRNewswire/ -- Severe asthma, a much more complicated form of asthma, requires treatment with a high dose of steroid-based anti-inflammatory medications (also known as inhaled corticosteroids [...]

Byline: Beth Gilbert The annual meeting of the American College of Allergy, Asthma & Immunology was held from Nov. 10 to 14 in Louisville, Kentucky, and attracted approximately 3,500 participants [...]

Toronto: Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) freut sich, den Abschluss einer Ubernahmevereinbarung bekannt zu geben. Intelligent AcuVidTM COVID-19 antigen-Speichel-Schnell tests are being developed, as are other advanced diagnostic [...]

PARSIPPANY, N.J.: Teva Pharmaceutical Industries Limited has issued the following news release: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that full [...]

FRIDAY, July 22, 2022 (HealthDay News) -- Long-term treatment of severe asthma with dupilumab supports sustained reduction in oral corticosteroid dosage and improvement in clinical end points for up to [...]

Byline: By, Mark Waghorn & Rachel Hains A llama's immune system is far more effective at fighting the virus than a human's, say scientists. It releases powerful chemicals that bind [...]

Results from Phase III trials conducted by Avillion in over 4,000 patients show that PT027, a novel fixed-dose combination of albuterol and budesonide, significantly reduced the risk of a severe [...]

CAMBRIDGE, England -- The following information was released by AstraZeneca: First time an albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations MANDALA Phase III trial results [...]

VIENNA, Va. -- The following information was released by the Allergy & Asthma Network: With more than 24 million Americans living with asthma and 50+ million with allergies, it's vital [...]

VIENNA, Va., May 2, 2022 /PRNewswire/ -- With more than 24 million Americans living with asthma and 50+ million with allergies, it's vital they have greater access to medical care [...]

BOSTON: Analysis Group has issued the following news release: Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), and AstraZeneca have published results from their [...]

BOSTON, April 5, 2022 /PRNewswire/ -- Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), and AstraZeneca have published results from their ZEPHYR 1 study, [...]

BOSTON, MA -- The following information was released by the Institute for Healthcare Improvement (IHI): By Nana Twum-Danso When an eight-year-old with a history of asthma presents to the emergency [...]

Lupin announced that its UK subsidiary, Lupin Healthcare (UK) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Luforbecà (beclometasone dipropionate/formoterol fumarate dihydrate) 100/6 ôg [...]

Analyses From NAVIGATOR and PATHWAY Trials Presented at the 2022 AAAAI Annual Meeting THOUSAND OAKS, Calif., Feb. 26, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from a pooled post-hoc [...]

TUESDAY, Feb. 8, 2022 (HealthDay News) -- Switching from a pressurized metered dose inhaler (pMDI)-based to a dry powder inhaler -based maintenance therapy reduces environmental impacts and does not worsen [...]

Asthma and bronchiectasis patients with chronic rhinosinusitis are associated with increased healthcare utilization according to research from the 2022 AAAAI Annual Meeting. Milwaukee, WI, Feb. 1, 2022 /PRNewswire-PRWeb/ -- Chronic [...]

- This content was sponsored by GSK. Jenna is a real patient who was on treatment at the time of these interviews. GSK paid for her time and expenses in [...]

- This content was sponsored by GSK. Jenna is a real patient who was on treatment at the time of these interviews. GSK paid for her time and expenses in [...]

REDWOOD CITY, Calif.,: Allakos Inc., a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced it has initiated a randomized, double-blind, placebo-controlled Phase [...]

Integrating data from the Propeller platform into Dignity Health's EHR improves clinical and operational efficiencies and provides physicians with real-time insights to improve patient treatment decisions SAN FRANCISCO, Oct. 5, [...]